IN2013MU03641A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03641A IN2013MU03641A IN3641MU2013A IN2013MU03641A IN 2013MU03641 A IN2013MU03641 A IN 2013MU03641A IN 3641MU2013 A IN3641MU2013 A IN 3641MU2013A IN 2013MU03641 A IN2013MU03641 A IN 2013MU03641A
- Authority
- IN
- India
- Prior art keywords
- amorphous form
- idelalisib
- relates
- abstract
- processes
- Prior art date
Links
- YKLIKGKUANLGSB-HNNXBMFYSA-N idelalisib Chemical compound C1([C@@H](NC=2[C]3N=CN=C3N=CN=2)CC)=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1 YKLIKGKUANLGSB-HNNXBMFYSA-N 0.000 abstract 3
- 229960003445 idelalisib Drugs 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000724 WO2015092810A2 (en) | 2013-11-20 | 2014-11-19 | Amorphous form of idelalisib |
| IN3641MU2013 IN2013MU03641A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2013-11-20 | 2014-11-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3641MU2013 IN2013MU03641A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2013-11-20 | 2014-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03641A true IN2013MU03641A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2015-07-31 |
Family
ID=52785145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3641MU2013 IN2013MU03641A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2013-11-20 | 2014-11-19 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03641A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) |
| WO (1) | WO2015092810A2 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016097314A1 (en) * | 2014-12-19 | 2016-06-23 | Sandoz Ag | Amorphous and crystalline forms of idelalisib and process for forming the same |
| US20180064714A1 (en) * | 2015-03-13 | 2018-03-08 | Mylan Laboratories Ltd | Process for the Preparation of Amorphous Idelalisib and its Premix |
| WO2016157136A1 (en) | 2015-04-02 | 2016-10-06 | Mylan Laboratories Ltd | Crystalline forms of idelalisib |
| CN104892612B (zh) * | 2015-04-15 | 2017-12-19 | 上海方楠生物科技有限公司 | 一种艾德力布的无定型物及其制备方法 |
| WO2017137097A1 (en) * | 2016-02-12 | 2017-08-17 | Synthon B.V. | Pharmaceutical composition comprising idelalisib in amorphous form |
| WO2017175184A1 (en) * | 2016-04-07 | 2017-10-12 | Laurus Labs Limited | Process for preparation of amorphous form of idelalisib |
| EP3272348A1 (en) | 2016-07-21 | 2018-01-24 | LEK Pharmaceuticals d.d. | Pharmaceutical composition comprising idelalisib |
| WO2019178596A1 (en) | 2018-03-16 | 2019-09-19 | Johnson Matthey Public Limited Company | Pyridine or n,n-dimethyl acetamide solvated solid state forms of solvated idelalisib, their use and preparation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1761540T (pt) | 2004-05-13 | 2016-12-07 | Icos Corp | Quinazolinonas como inibidores de fosfatidilinositol-3-cinase delta humana |
| CN106146506A (zh) | 2012-03-05 | 2016-11-23 | 吉利德卡利斯托加公司 | (s)‑2‑(1‑(9h‑嘌呤‑6‑基氨基)丙基)‑5‑氟‑3‑苯基喹唑啉‑4(3h)‑酮的多晶型物 |
-
2014
- 2014-11-19 IN IN3641MU2013 patent/IN2013MU03641A/en unknown
- 2014-11-19 WO PCT/IN2014/000724 patent/WO2015092810A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015092810A3 (en) | 2015-08-13 |
| WO2015092810A2 (en) | 2015-06-25 |